Our Unique Consortium

Sydney Catalyst is a multi-disciplinary, multi-institutional endeavour established with core funding from the Cancer Institute NSW and based at the University of Sydney.

Read more

Event
Scaling New Heights: PhD Opportunities Showcase

Workshops and Masterclasses

Scaling New Heights: PhD Opportunities Showcase

Are you thinking about undertaking a PhD in cancer research? Are you wondering "what's next?"  Join us for our 'Scaling New Heights: PhD Opportunities Showcase' to hear about some amazing op...

Read more
Event
EDS: Immunology & Cancer

Education Dinner Series

EDS: Immunology & Cancer

Save the date for our next Education Dinner Series Event on Immunology & Cancer. For the fifth year running, we'll be holding this event in conjunction with DC Down Under and Professor D...

Read more
Event
SCITCRS2017

Symposia

SCITCRS2017

The 2017 Sydney Catalyst International Translational Research Symposium is coming soon. While the program for the day is still under development, we are delighted to confirm international guest P...

Read more
Event
Melanoma Institute Medical Oncology Fellowships

Funding and Opportunities

Melanoma Institute Medical Oncology Fellowships

The Melanoma Institute Australia is advertising Medical Oncology Fellowships for 2018. For more information: Download Position Description Download Selection Criteria

Read more
News
Sydney Catalyst June 2017 Newsletter

Newsletters

Sydney Catalyst June 2017 Newsletter

This month we're talking about the CNRU, ASCO 2017, our brand new Pilot & Seed funding recipients and about how our Travel & Education Awards have supported lung cancer research....

Read more
Research
Daniel Steffens & team: Feasibility and acceptability of pre-operative exercise to improve patient outcomes after major cancer surgery: A pilot randomised controlled trial

T2,T3 | Flagship 2 Pilot and Seed

Daniel Steffens & team: Feasibility and acceptability of pre-operative exercise to improve patient outcomes after major cancer surgery: A pilot randomised controlled trial

Promoting physical activity in the pre-operative period appears promising to improve functional capacity and facilitate post-operative recovery. This pilot study will establish the feasibility and...

Read more
Clinical TrialsExercise
Research
Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma

T1 | Flagship 2 Pilot and Seed

Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma

Immune checkpoint inhibitor therapy has provided new hope to cancer patients whose tumours have resisted conventional therapy. One of the most recent success stories has been effective treatment o...

Read more
ImmunotherapyNew therapies and diagnosticsLung cancerMesothelioma
Research
Sydney Catalyst: Embedding Research in Cancer Healthcare (EnRICH)

T1,T2,T3 | Flagship 1 EnRICH

Sydney Catalyst: Embedding Research in Cancer Healthcare (EnRICH)

The program will develop infrastructure to support translational cancer research, initially with a focus on lung cancer. Specifically, EnRICH will assemble a prospective cohort of 1000 newly diagn...

Read more
Epidemiology and health services researchImplementation researchKnowledge translationLung cancer
Research
Mark Larance: Nutrient Deprivation and the Protective Proteome for the Prevention of Disease

T1 | Sydney Catalyst Supported

Mark Larance: Nutrient Deprivation and the Protective Proteome for the Prevention of Disease

Cancer is a major cause of illness and death in Australia. Key risk factors for colorectal cancer and many other cancer types are poor diet, obesity and age. In animals, short periods of nutrient ...

Read more
Cancer metabolismColorectal cancerProteomics